Your golden years should be about peace of mind—not worrying about the cost of staying alive.
For those living with HIV, access to medication isn’t optional—it’s lifelong.
But when Gilead's Biktarvy to treat HIV can cost nearly $61,000 a year 💸, that stability is constantly at risk.
After decades of working, building a life, and contributing to society, no one should have to spend their golden years wondering if they can afford the care they need.
This is why we’re out here at
@GileadSciences HQ 📍
Because growing older should come with dignity—not uncertainty.
Lower the price. Protect access. Let people live.